Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma

BMJ Case Rep. 2014 Jul 31:2014:bcr2013203180. doi: 10.1136/bcr-2013-203180.

Abstract

Adenoid cystic carcinoma (ACC) is a rare type of cancer that typically originates in the salivary glands. Surgical removal can lead to functional loss and psychological distress. Viscum album extract (VAE) is a herbal remedy with dose-dependent cytotoxic, apoptogenic and immunological effects. In some case reports, tumour regression has been observed following high-dose local applications of VAE. An active 88-year-old man with fast-growing ACC of the hard palate refused surgical removal and received high-dose intratumoural injections of VAE (alone) over a 10-month period. The tumour decreased in size, softened and loosened from its surroundings. A biopsy during the course showed inflammation. The patient remained well and without functional limitations during the therapy and follow-up period (5 months). VAE produced no reported side effects. This aged patient exemplifies a satisfying course of ACC under VAE resulting in good quality of life and partial tumour regression.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Biopsy
  • Carcinoma, Adenoid Cystic / diagnosis
  • Carcinoma, Adenoid Cystic / drug therapy*
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Humans
  • Injections, Intralesional
  • Male
  • Mouth Neoplasms / diagnosis
  • Mouth Neoplasms / drug therapy*
  • Palate, Hard
  • Phytotherapy / methods*
  • Plant Preparations / administration & dosage*
  • Time Factors
  • Viscum album*

Substances

  • Plant Preparations